Official data from INPI

112026013971

Em AnáliseInvention PatentPCT · US2024058918

Talk to an expert

Application data

Number

112026013971

Type

Invention Patent

Filing

12/06/2024

Publication

PCT

US2024058918

View on INPI

Progress at the INPI

Examination not yet requested

Filing12/06/24
Publication
Examination
Allowance
Grant
In force

Examination has not been requested yet. Without that request by 12/06/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:12/06/2027(468 days left)

Latest action published by the INPI: 06/16/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MAXCYTE, INC.

Inventors

No inventors listed.

Technical data

IPC Classification

C12N 15/86 C12N 15/87

Priority claims

63/608,085 · 12/08/2023

63/640,415 · 04/30/2024

63/642,346 · 05/03/2024

63/654,447 · 05/31/2024

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Alteração de dados cadastrais

#1.1

06/16/2026

RPI 2893

From the same holder

112026016213 112026008079 MÉTODO DE ELETROPORAÇÃO DE CÉLULAS MÉTODO DE TRANSDUÇÃO VIRAL APRIMORADA COM USO DE ELETROPORAÇÃO MÉTODOS DE ELETROPORAÇÃO SEQUENCIAL SISTEMAS E MÉTODOS PARA ELETROPORAÇÃO

Same category

PP1101201 PP1101199 "COMPOSTO, PROCESSO PARA A PREPARAÇÃO DO SAL DE Na DO (-)-ENANTIOMERO DE OMEPRAZOL, PREPARAÇÃO FARMACÉUTICA E USO DE UM COMPOSTO.PP1101197 PROTEÍNAS QUE LIGAM TNF PP1101194 DERIVADOS CONDENSADOS DO BENZOPIRROL COMO ANTAGONISTAS RECEPTORES DO 5-HT4 PP1101192

Explore category

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.